Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T04:03:40.212Z Has data issue: false hasContentIssue false
  • English
  • Français

Depressive and Extrapyramidal Symptoms and Clinical Effects: A Trial of Fluphenazine versus Flupenthixol in Maintenance of Schizophrenic Out-patients

Published online by Cambridge University Press:  29 January 2018

Angela Knights ,
M. S. Okasha ,
Mohamed Ali Salih  and
S. R. Hirsch
Angela Knights
Affiliation:
Department of Psychiatry, Charing Cross Hospital, London W6 8RF
M. S. Okasha
Affiliation:
12 Case Street, Norwich, Connecticut 06360. Tale University School of Medicine
Mohamed Ali Salih
Affiliation:
Whitecroft Hospital, Isle of Wight
S. R. Hirsch
Affiliation:
Department of Psychiatry, Charing Cross Hospital, London W6 8RF
Get access Rights & Permissions [Opens in a new window]

Summary

Fifty-seven patients with a diagnosis of schizophrenia were started on either fluphenazine decanoate or flupenthixol decanoate injections in a double-blind trial just prior to discharge into the community. During the six month follow-up 30 per cent dropped out of the treatment. Of those observed for six months, 7 per cent relapsed, 54 per cent experienced depressive symptoms and 88 per cent extrapyramidal side-effects. Analysis of both clinical data and the ratings failed to discriminate between the two drugs.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 135 , Issue 6 , December 1979 , pp. 515 - 523
Copyright
Copyright © Royal College of Psychiatrists, 1979 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alarcon, R. de & Carney, M. W. P. (1969) Severe depressive mood changes following slow release intra-muscular fluphenazine injection. British Medical Journal, iii, 564–7.Google Scholar
Carney, M. W. P. & Sheffield, B. F. (1973) The long term maintenance treatment of schizophrenic outpatients with depot flupenthixol. Current Medical Research and Opinion, 1, 423–6.CrossRefGoogle Scholar
Chien, Ching-Piao, Dimascio, A. & Cole, J. O. (1974) Antiparkinsonian agents and depot phenothiazines. American Journal of Psychiatry, 131, 86–90.CrossRefGoogle Scholar
Hall, P. & Coleman, J. (1972) Flupenthixol in the treatment of schizophrenia. British Journal of Psychiatry, 120, 241–2.Google ScholarPubMed
Haslam, M. T., Bromham, B. M. & Schiff, A. A. (1975) A comparative trial of fluphenazine decanoate and flupenthixol decanoate. Acta Psychiatrica Scandinavica, 51, 92–100.CrossRefGoogle ScholarPubMed
Hirsch, S. R., Gaind, R., Rohde, P. D., Stevens, B. C. & Wing, J. K. (1973) Out-patient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. British Medical Journal, i, 633–7.Google Scholar
Johnson, D. A. W. (1973) The side-effects of fluphenazine decanoate. British Journal of Psychiatry, 123, 519–22.CrossRefGoogle ScholarPubMed
Johnson, D. A. W. & Freeman, H. (1973) Drug-defaulting by patients on long-acting phenothiazines. Psychological Medicine, 3, 115–9.CrossRefGoogle ScholarPubMed
Johnson, D. A. W. & Malik, N. A. (1975) A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia. Acta Psychiatrica Scandinavica, 51, 257–67.CrossRefGoogle ScholarPubMed
Kelly, H. B., Freemantle, H. L., Banning, B. & Schiff, A. A. (1977) Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia. International Pharmacopsychiatry, 12, 56–64.CrossRefGoogle ScholarPubMed
Kennedy, P. F., Hershon, H. I. & McGuire, R. J. (1971) Extrapyramidal disorders after prolonged phenothiazine therapy. British Journal of Psychiatry, 118, 509–18.CrossRefGoogle ScholarPubMed
Martin, I. C. A. & Townend, R. A. (1974) Implications of sustained release phenothiazines: a study of fluphenazine decanoate. British Journal of Psychiatry, 124, 173–6.CrossRefGoogle ScholarPubMed
Mindham, R. I., Gaind, R. & Anstee, B. H. (1972) Comparison of orphenadrine and placebo on the control of phenothiazine-induced parkinsonism. Psychological Medicine, 2, 406–13.CrossRefGoogle ScholarPubMed
Okasha, M. S., Hirsch, S. R., Knights, Angela & Salih, , Ali, M. (1978) Flupenthixol and fluphenazine decanoate—a comparative review. Psychiatric Annals, 8, 350–5.CrossRefGoogle Scholar
Trueman, H. R. & Valentine, M. G. (1974) Flupenthixol decanoate in schizophrenia. British Journal of Psychiatry, 124, 58–9.CrossRefGoogle ScholarPubMed
Van Putten, T. & May, P. R. A. (1978) Akinetic depression in schizophrenia. Archives of General Psychiatry, 35, 1101–7.CrossRefGoogle ScholarPubMed
Vaughn, C. E. & Leff, J. P. (1976) The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients. British Journal of Psychiatry, 129, 125–37.CrossRefGoogle ScholarPubMed
Wing, J. K., Cooper, J. E. & Sartorius, N. (1974) The Measurement and Classification of Psychiatric Symptoms, Cambridge University Press.Google Scholar
Young, J. P. R., Hughes, W. C. & Lader, M. H. (1976) A controlled comparison of fluphenazine amitriptyline in depressed out-patients. British Medical Journal, i, 1116–8.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.